MediGene AG (MDGEF)

0.10 0.00 (0.00%) USD  |  OTCM  |  Sep 02, 16:00
More

MediGene Cash and Short Term Investments (Quarterly)

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for MDGEF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2019 61.38M
September 30, 2019 65.97M
June 30, 2019 74.31M
March 31, 2019 62.37M
December 31, 2018 58.77M
September 30, 2018 51.49M
June 30, 2018 57.02M
March 31, 2018 60.39M
December 31, 2017 62.11M
September 30, 2017 65.46M
June 30, 2017 68.29M
March 31, 2017 51.39M
December 31, 2016 55.51M
September 30, 2016 49.00M
June 30, 2016 54.07M
March 31, 2016 52.77M
December 31, 2015 50.79M
September 30, 2015 56.67M
June 30, 2015 11.21M
March 31, 2015 14.12M
December 31, 2014 18.12M
September 30, 2014 21.08M
June 30, 2014 5.609M
March 31, 2014 9.952M
December 31, 2013 14.01M
Date Value
September 30, 2013 15.78M
June 30, 2013 19.45M
March 31, 2013 21.41M
December 31, 2012 26.52M
September 30, 2012 28.62M
June 30, 2012 32.20M
March 31, 2012 13.48M
December 31, 2011 16.63M
September 30, 2011 20.63M
June 30, 2011 22.99M
March 31, 2011 26.68M
September 30, 2010 14.72M
June 30, 2010 10.04M
March 31, 2010 11.07M
December 31, 2009 17.58M
September 30, 2009 14.15M
June 30, 2009 18.97M
March 31, 2009 22.10M
December 31, 2008 34.89M
September 30, 2008 41.92M
June 30, 2008 51.16M
March 31, 2008 59.60M
December 31, 2007 68.00M
September 30, 2007 77.59M
June 30, 2007 62.90M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
InflaRx NV 181.23M
BioNTech SE 16.89B
Immatics NV 449.72M
Arrowhead Pharmaceuticals, Inc. 1.602B
Oncolytics Biotech, Inc. 4.115M